Fmoc-Asp(OtBu)-(Hmb)Gly-OH is a protected amino acid derivative used as a peptide-coupling building block, combining an Fmoc-protected aspartic acid residue with an Asp side-chain tert-butyl ester and an (Hmb)-protected glycine component linked in a dipeptide-like arrangement. The molecule contains an Fmoc carbamate on the amino terminus, a tert-butyl ester protecting group on the aspartate side-chain carboxyl group, and an Hmb (hexamethylbenzyloxycarbonyl) protecting group on the glycine amino function, while retaining a free C-terminal carboxylic acid (-OH) for further coupling. In synthesis workflows such as stepwise or solid-phase peptide assembly, these orthogonal protecting groups support chemoselective deprotection and subsequent amide bond formation, and the protected dipeptide motif is also used for preparing more complex amino acid and peptide derivatives for structural or analytical studies.
CAT No: CP27155
CAS No:502640-94-0
Synonyms/Alias:Fmoc-L-Asp(OtBu)-HmbGly-OH;502640-94-0;AC1MBT45;Fmoc-Asp(Otbu)-(Hmb)Gly-OH;CTK8E8849;C33H36N2O9;6794AH;ZINC71788155;RT-012972;Fmoc-Asp(OtBu)-N-(2-hydroxy-4-methoxy-Bzl)-Gly-OH;2-[[(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-4-[(2-methylpropan-2-yl)oxy]-4-oxobutanoyl]-[(2-hydroxy-4-methoxyphenyl)methyl]amino]aceticacid
Fmoc-Asp(OtBu)-(Hmb)Gly-OH is a protected dipeptide-like amino acid building block featuring an Fmoc-protected amino group at the N-terminus, a side-chain tert-butyl ester on the Asp residue (Asp(OtBu)), and an Hmb-protected glycine component (Hmb on the amine side of the Gly unit as a sterically demanding amine-protecting group). The molecule contains two carboxylic acid functionalities in the unprotected form (with one positioned on the Asp backbone and one at the C-terminus), along with a defined stereochemical relationship inherited from the Asp residue, which governs conformational preferences during peptide assembly. The presence of orthogonal protecting groups enables controlled deprotection sequences: acid-labile removal of OtBu and Hmb can be separated from base-labile Fmoc cleavage, allowing stepwise exposure of reactive amines and carboxylates. The resulting reactivity profile supports peptide coupling chemistry and downstream derivatization where Asp side-chain functionality and the protected glycine nitrogen can be sequentially unmasked for further synthetic elaboration.
1. Peptide Synthesis
Fmoc-Asp(OtBu)-(Hmb)Gly-OH is applied in solid-phase and solution-phase peptide synthesis workflows where orthogonally protected amine and side-chain groups are required for reliable coupling. The Fmoc group enables base-mediated N-terminal deprotection to generate a free amine for subsequent peptide bond formation, while the Asp(OtBu) ester protects the side-chain carboxylate from undesired acylation or side reactions during chain elongation. The Hmb-protected glycine unit helps preserve the glycine nitrogen under coupling conditions, supporting controlled stepwise assembly of Asp-containing sequences and reducing cross-reactivity between nucleophilic sites. The compound can be used as a dipeptide building block to introduce an Asp(OtBu) motif into peptide chains, supporting synthesis of peptide analogs that require later side-chain deprotection for native carboxylate presentation.
2. Protected Amino Acid Chemistry
Fmoc-Asp(OtBu)-(Hmb)Gly-OH serves as a chiral, protected amino acid derivative platform for studying amino acid derivatization strategies and orthogonal protecting-group logic. The molecule's Asp side-chain tert-butyl ester and Hmb-protected amine provide chemically distinct handles that can be selectively removed under conditions tailored to acid-labile groups, while the Fmoc group remains stable to many coupling environments and is removed under basic conditions. The dual carboxylate-bearing architecture allows controlled formation of activated derivatives, including amide and ester linkages, during intermediate preparation for peptide fragments and functionalized analogs. Downstream use frequently includes generating Asp-containing intermediates for further functional group transformation, enabling systematic exploration of how side-chain deprotection timing affects peptide purity, sequence integrity, and subsequent conjugation steps.
3. Bioconjugation Linkers
Fmoc-Asp(OtBu)-(Hmb)Gly-OH is suitable for constructing Asp-based linker motifs in chemical biology and biomolecule modification programs that require carboxylate-bearing attachment points. The Asp side-chain carboxylate, once deprotected from the OtBu group, can participate in amide coupling or esterification to install handles for conjugation to proteins, peptides, or polymeric carriers. The Fmoc-protected N-terminus provides a controlled synthetic entry point for incorporating the dipeptide segment into larger constructs before final coupling, while the Hmb-protected glycine nitrogen helps maintain amine chemoselectivity during multi-step assembly. The resulting Asp-containing conjugation scaffold can be carried forward into downstream derivative formation such as affinity-tagged peptides, labeled biomolecule fragments, or modular linker systems used in applied biochemical research and industrial fine chemical synthesis.
4. Process Chemistry Intermediate
Fmoc-Asp(OtBu)-(Hmb)Gly-OH is used as a defined intermediate in process chemistry settings focused on reproducible peptide fragment manufacture and protected building block supply. The orthogonal protection scheme supports manufacturing route design where Fmoc removal and acid-labile deprotections can be sequenced to minimize side reactions involving the Asp side-chain carboxylate and the glycine amine. The molecule's stable protected functionalities under typical peptide coupling conditions support scalable handling as a discrete, isolable unit for downstream chain extension, enabling consistent feedstock composition for peptide manufacturing operations. The dipeptide-like structure also supports batch-to-batch reproducibility in intermediate preparation for peptide-based reagents, peptidomimetic fragments, and other amino acid-derived specialty chemicals where protection strategy is a key determinant of process robustness.
5. Structure-Activity Relationship Studies
Fmoc-Asp(OtBu)-(Hmb)Gly-OH is applied in SAR-oriented peptide and peptidomimetic design efforts where systematic variation of Asp-containing motifs requires precise control over side-chain availability. The Asp(OtBu) group allows the side-chain carboxylate to remain masked during early synthetic steps, enabling the construction of analog libraries with consistent backbone assembly before final deprotection to reveal the native Asp functionality. The Fmoc group supports iterative peptide coupling, facilitating the generation of series of derivatives that differ in length, terminal modifications, or neighboring residues while keeping the Asp side-chain chemistry controlled. The Hmb-protected glycine component contributes to chemoselective assembly by limiting premature amine exposure, which can otherwise complicate library synthesis. The compound thus functions as a practical amino acid-based intermediate for generating structured peptide analogs used in mechanistic studies, binding studies, and comparative evaluation of structure-function relationships.
3. Cationic cell-penetrating peptides are potent furin inhibitors
5. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.